# A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma

> **NCT07433569** · PHASE1 · RECRUITING · sponsor: **AstraZeneca** · enrollment: 12 (estimated)

## Conditions studied

- Asthma

## Interventions

- **COMBINATION_PRODUCT:** Budesonide/formoterol fumarate Aerosphere
- **COMBINATION_PRODUCT:** Budesonide/formoterol fumarate pMDI

## Key facts

- **NCT ID:** NCT07433569
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-05
- **Primary completion:** 2026-10-23
- **Final completion:** 2026-10-23
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433569, "A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07433569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*